Bristol-Myers Squibb Co
XMUN:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
HIVE Blockchain Technologies Ltd
XTSX:HIVE
|
CA |
|
P
|
Perdoceo Education Corp
XMUN:CE1
|
US |
|
L
|
L'Oreal SA
XBER:LOR
|
FR |
|
D
|
DaVita Inc
F:TRL
|
US |
|
Andritz AG
F:AZ2
|
AT |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
Kardex Holding AG
SIX:KARN
|
CH |
|
National Energy Services Reunited Corp
OTC:NESR
|
US |
|
A
|
Andritz AG
VSE:ANDR
|
AT |
|
D
|
Dialight PLC
OTC:DIALF
|
UK |
|
P
|
Pexip Holding ASA
XMUN:4W9
|
NO |
|
Christian Dior SE
PAR:CDI
|
FR |
|
Brooks Laboratories Ltd
NSE:BROOKS
|
IN |
|
Roche Holding AG
SIX:ROG
|
CH |
|
Almonty Industries Inc
TSX:AII
|
CA |
|
Nestle SA
F:NESR
|
CH |
|
NBCC (India) Ltd
NSE:NBCC
|
IN |
|
Paleo Resources Inc
XTSX:PRE
|
CA |
|
A
|
Absa Bank Ltd
JSE:ABSP
|
ZA |
|
Guillemot Corporation SA
F:GUL
|
FR |
|
I
|
Indegene Ltd
NSE:INDGN
|
IN |
|
R
|
Renta 4 Banco SA
MAD:R4
|
ES |
|
Metso Outotec Corp
OTC:OUKPY
|
FI |
Bankruptcy Probability
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bristol-Myers Squibb Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
961.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
552.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
279.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
47.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bristol-Myers Squibb Co has total debt of 42.5B USD. This includes both short-term (319m USD) and long-term (42.2B USD) debt.
You can find a full breakdown on its Balance Sheet.
